-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In the past few decades, the incidence of thyroid cancer has increased
.
From 1975 to 2009, the incidence of thyroid cancer in the United States increased from 4.
Quality of life Recently, researchers investigated the impact of total thyroidectomy or lobectomy on the quality of life of patients with low to moderate risk of recurrence
This prospective observational longitudinal cohort study included patients who were diagnosed with DTC at the First Affiliated Hospital of Sun Yat-sen University in China from October 1, 2018 to September 31, 2019, and were randomly assigned to undergo total thyroidectomy (TT group) ) Or thyroid lobectomy (TL group)
.
The patients were evaluated before surgery, followed up at 1, 3, 6, and 12 months after the operation.
diagnosis
1060 patients participated in the study, 563 received TL (438 women [77.
8%]; median age 38 years), and 497 received TT (390 women [78.
5%]; median age 38 years)
.
Compared with the TL group (including the 1-4cm tumor subgroup), the TT group had more postoperative health quality of life problems at 1 and 3 months after surgery.
Compared with the TL group (including the 1-4cm tumor subgroup), the TT group had more postoperative health quality of life problems at 1 and 3 months after surgery.
Differences in postoperative thyroid cancer-specific quality of life questionnaires between groups
Differences in postoperative thyroid cancer-specific quality of life questionnaires between groups difference in postoperative thyroid cancer-specific quality of life questionnairesStudies have found that for patients with differentiated thyroid cancer with a low-to-medium risk of recurrence, the long-term postoperative quality of life of patients has nothing to do with the scope of surgical resection, but if a better quality of life is pursued in the short term, thyroid lobectomy is the first choice
For patients with differentiated thyroid cancer with a moderate to low risk of recurrence, the long-term postoperative quality of life of the patient has nothing to do with the scope of surgical resection.
Original source:
Wanna Chen et al.
Association of Total Thyroidectomy or Thyroid Lobectomy With the Quality of Life in Patients With Differentiated Thyroid Cancer With Low to Intermediate Risk of Recurrence.
JAMA is here to leave a message
